| Literature DB >> 22963728 |
Cristiane Bregge-Silva1, Maria Cristina Nonato, Sérgio de Albuquerque, Paulo Lee Ho, Inácio L M Junqueira de Azevedo, Marcelo Ribeiro Vasconcelos Diniz, Bruno Lomonte, Alexandra Rucavado, Cecilia Díaz, José María Gutiérrez, Eliane Candiani Arantes.
Abstract
The aim of this study was the isolation of the LAAO from Lachesis muta venom (LmLAAO) and its biochemical, functional and structural characterization. Two different purification protocols were developed and both provided highly homogeneous and active LmLAAO. It is a homodimeric enzyme with molar mass around 120 kDa under non-reducing conditions, 60 kDa under reducing conditions in SDS-PAGE and 60852 Da by mass spectrometry. Forty amino acid residues were directly sequenced from LmLAAO and its complete cDNA was identified and characterized from an Expressed Sequence Tags data bank obtained from a venom gland. A model based on sequence homology was manually built in order to predict its three-dimensional structure. LmLAAO showed a catalytic preference for hydrophobic amino acids (K(m) of 0.97 mmol/L with Leu). A mild myonecrosis was observed histologically in mice after injection of 100 μg of LmLAAO and confirmed by a 15-fold increase in CK activity. LmLAAO induced cytotoxicity on AGS cell line (gastric adenocarcinoma, IC₅₀: 22.7 μg/mL) and on MCF-7 cell line (breast adenocarcinoma, IC₅₀:1.41 μg/mL). It presents antiparasitic activity on Leishmania brasiliensis (IC₅₀: 2.22 μg/mL), but Trypanosoma cruzi was resistant to LmLAAO. In conclusion, LmLAAO showed low systemic toxicity but important in vitro pharmacological actions.Entities:
Mesh:
Substances:
Year: 2012 PMID: 22963728 DOI: 10.1016/j.toxicon.2012.08.008
Source DB: PubMed Journal: Toxicon ISSN: 0041-0101 Impact factor: 3.033